CA2333556A1 - Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine - Google Patents

Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine Download PDF

Info

Publication number
CA2333556A1
CA2333556A1 CA002333556A CA2333556A CA2333556A1 CA 2333556 A1 CA2333556 A1 CA 2333556A1 CA 002333556 A CA002333556 A CA 002333556A CA 2333556 A CA2333556 A CA 2333556A CA 2333556 A1 CA2333556 A1 CA 2333556A1
Authority
CA
Canada
Prior art keywords
composition
isoflavonoid
isoflavonoids
dietary product
migraine headaches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002333556A
Other languages
English (en)
Inventor
Sherwood L. Gorbach
Barry R. Goldin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2333556A1 publication Critical patent/CA2333556A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé de traitement ou de prévention, chez une personne, d'un ou de plusieurs symptômes de céphalées du type migraine, ce procédé consistant à administrer à cette personne, oralement ou au moyen d'un système ou timbre transdermique, une composition comprenant un ou plusieurs isoflavonoïdes purifiés, choisis dans le groupe constitué par génistéine, daïdzéine, biochanine A, formononétine, O-desméthylangolensine, glycitéine, équol et dihydrodaïdzéine, et les conjugués de ceux-ci.
CA002333556A 1998-05-27 1999-05-25 Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine Abandoned CA2333556A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8548098A 1998-05-27 1998-05-27
US09/085,480 1998-05-27
PCT/US1999/011532 WO1999061028A1 (fr) 1998-05-27 1999-05-25 Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine

Publications (1)

Publication Number Publication Date
CA2333556A1 true CA2333556A1 (fr) 1999-12-02

Family

ID=22191888

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002333556A Abandoned CA2333556A1 (fr) 1998-05-27 1999-05-25 Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine

Country Status (4)

Country Link
EP (1) EP1082122A4 (fr)
AU (1) AU4204099A (fr)
CA (1) CA2333556A1 (fr)
WO (1) WO1999061028A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132084A1 (fr) * 2000-03-06 2001-09-12 Docteur Nature Srl Dispositif d'administration transdermique destiné à la libération lente de phytoestrogènes provenant de soja
ATE343415T1 (de) 2001-06-29 2006-11-15 Ab Science Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
JP2005500041A (ja) 2001-06-29 2005-01-06 アブ サイエンス 強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤
PT1401413E (pt) 2001-06-29 2007-02-28 Ab Science Uso de inibidores da tirosina cinase para tratar doenças alérgicas
ATE330608T1 (de) 2001-06-29 2006-07-15 Ab Science Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
AU2003216625A1 (en) * 2002-02-27 2003-09-09 Ab Science Use of tyrosine kinase inhibitors for treating cns disorders
CA2492754C (fr) 2002-07-24 2018-05-22 Children's Hospital Medical Center Compositions et produits contenant de l'equol enantiomere, et procedes de fabrication
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CA2504682A1 (fr) 2002-10-29 2004-05-13 Colorado State University Research Foundation Utilisation d'equol dans le traitement de maladies d'origine androgenique
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
EP1773287A1 (fr) * 2004-07-23 2007-04-18 The Procter and Gamble Company Dispositif de soin cutané à base de substrat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses

Also Published As

Publication number Publication date
EP1082122A1 (fr) 2001-03-14
AU4204099A (en) 1999-12-13
EP1082122A4 (fr) 2003-04-09
WO1999061028A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
US5498631A (en) Method for treatment of menopausal and premenstrual symptoms
AU724813B2 (en) Isoflavonoids for treatment and prevention of Alzheimer dementia and reduced cognitive functions
US6060070A (en) Isoflavonoids for treatment and prevention of aging skin and wrinkles
EP0656786B1 (fr) Utilisation d'extraits des phyto-estrogenes d'isoflavones a partir de soja ou de trefle
CA2287965C (fr) Traitement ou prevention des symptomes menopausiques et de l'osteoporose
US6083526A (en) Use of isoflavonoids in the treatment or prevention of postpartum depression
US4886665A (en) Compositions of oats and nettle extracts to be used as a food additive or pharmaceutical preparation in human health care
Benlhabib et al. Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol
CA2331185A1 (fr) Compose permettant d'accroitre la densite osseuse
CA2333556A1 (fr) Isoflavonoides utiles dans le traitement et la prevention de maux de tete du type migraine
CN100366628C (zh) 槐角黄酮有效部位、生产方法及其应用
EP1618875B1 (fr) Composition destinee a l'inhibition ou a la prevention de la baisse de la densite osseuse
US20020022634A1 (en) Method for treating alcohol intoxication and alcohol abuse
JP2002029975A (ja) フリーラジカル消去剤
JPH08231533A (ja) 新規フラボノイド配糖体およびフラボノイド配糖体を含む骨粗鬆症治療剤ならびに可食性組成物
Montanari et al. Health promoting phytochemicals in citrus fruit and juice products
JP2004210675A (ja) 骨量改善組成物
JP2004196751A (ja) 更年期症状改善組成物
JP3250071B2 (ja) 抗骨粗鬆症組成物
WO2006003750A1 (fr) Agent anti-inflammatoire/préventif de l'inflammation, produit pharmaceutique, aliment ou boisson et parfum ou cosmétique
AU7017198A (en) Treatment or prevention of menopausal symptoms and osteoporosis

Legal Events

Date Code Title Description
FZDE Discontinued